Organic compounds -- part of the class 532-570 series – Organic compounds – Carbohydrates or derivatives
Reexamination Certificate
2005-11-01
2005-11-01
Housel, James (Department: 1648)
Organic compounds -- part of the class 532-570 series
Organic compounds
Carbohydrates or derivatives
C435S069100, C435S069300, C435S069700, C424S192100, C424S228100
Reexamination Certificate
active
06960659
ABSTRACT:
A mosaic protein comprising a variety of immunoreactive antigenic epitopes from several genotypes of hepatitis C virus. The mosaic protein provides a sensitive and specific immunological hepatitis detection assay. A restriction enzyme assisted ligation method of making an artificial gene permits controlled construction of mosaic proteins, and allows confirmatory expression of the intermediate gene products.
REFERENCES:
patent: 5106726 (1992-04-01), Wang
patent: 5302507 (1994-04-01), Chiba et al.
patent: 5436126 (1995-07-01), Wang
patent: 5436318 (1995-07-01), Reyes et al.
patent: 5443965 (1995-08-01), Reyes et al.
patent: 5538865 (1996-07-01), Reyes et al.
patent: 5563032 (1996-10-01), Fields et al.
patent: 5574132 (1996-11-01), Lacroix
patent: 5625034 (1997-04-01), Liao et al.
patent: 6428792 (2002-08-01), Valenzuela et al.
patent: 97/05164 (1999-02-01), None
patent: 95/09239 (1995-04-01), None
patent: 95/21858 (1995-08-01), None
International Committee on the Taxonomy of Viruses, Index of Viruses, at http://www.ictvdb.iacr.ac.uk/ictv/fr-index.htm (Exhibits 1 and 2).
Division of Viral Hepatitis, Centers for Disease Control and Prevention, “Epidemiology and Prevention of Viral Hepatitis A to E: An Overview,” at http://www.cdc.gov
cidod/diseases/hepatitis/slideset/ .□□
Kumar et al., “Hepatitis B virus envelope epitopes: gene assembly and expression in Escherichica coli of an immunologically reactive novel multiple-epitope polypeptide 1(MEP-1),” Gene 110:137-144 (1992).
Yagi et al., “A Epitope Chimeric Anitgen for the Hepatitis C Virus Serological Screening Test,” Biol. Pharm. Bull. vol. 19 (10), pp. 1254-1260 (1996).
Bhattacherjee V, et al., Use of NS-4 peptides to identify type-specific antibody to hepatitis C virus genotypes 1, 2, 3, 4, 5 and 6, Journal of General Virology, 76 (Pt 7) p1737-48, Jul. 1995.
Maggi et al., Serological Reactivity and Viral Genotypes in Hepatitis C Virus Infection. Journal of Clinical Microbiology 33 (1):p209-211, 1995.
Nagayama et al., Genotype dependence of hepatitis C virus antibodies detectable bythe first-generation enzyme-linked immunosorbent assay with C100-3protein. Journal of clinical investigation, 92 (3) p1529-33, Sep. 1993.
Academic Press Dictionary of Science and Technology, On-line, Harcourt, Inc., Definition of “genotype”, Sep. 2001.
“Detection of Antibodies to Hepatitis C Virus (HCV) Structural Proteins in Anti-HCV-Positve Sera by an Enzyme-Linked Immunosorbent Assay Using Synthetic Peptides as Antigens”;Chuzo Ishida et al. Journal of Clinical Microbiology, vol. 31, No. 4, Apr. 1993, pp. 936-940.
“E2 and NS5: New Antigens for Detection of Hepatitis C Virus Antibodies”;H.L. Zaaijer et al., Journal of Medical Virology, 44:395-397, Apr. 25, 1994.
“Improved Diagnosis of Chronic Hepatitis C Virus Infection by Detection of Antibody to Multiple Epitopes: Confirmation by Antibody to Syunthetic Oligopeptides”,D. Brown et al., Journal of Medical Virology, 38:167-171, Apr. 3, 1992.
“Preformed Antigen-Antibody Complex to Detect Antibodies to Hepatitis C Virus”,Dinesh Shah, Clinical Chemistry, vol. 41, No. 9, 1357-58 , 1995.
“Study on Reliability of Commercially Available Hepatitis C Virus Antibody Tests”,H.H. Feucht et al., Journal of Clinical Microbiology, vol. 33, No. 3, Mar. 1995, pp. 620-624.
“Synthetic gene for the hepatitis C virus nucleocapsid protein”,Y. E. Khudyakov et al., Nucleic Acids Research, vol. 21, No. 11, pp. 2747-2754, Apr. 30, 1993.
“IgM and IgG Antbodies to Hepatitis E Virus (HEV) Detected by an Enzyme Immunoassay Based on an HEV-Specific Artificial Recombinant Mosaic Protein”,M.O. Favorov, Journal of Medical Virology, 50:50-58, May 9, 1996.
“Artificial Mosaic Protein Containing Antigenic Epitopes of Hepatitis E Virus”;Yury E. Khudyakov et al., Journal of Virology, vol. 68, No. 11, Nov. 1994, pp. 7067-7074.
“Solid-phase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides”,George J. Dawson et al., Journal of Virological Methods, 38 (1992) pp. 175-186.
“Influence of Viraemia and Genotype Upon Serological Reactivity in Screening Assays for Antibody to Hepatitis C Virus”,S.K. Dhaliwal et al., Journal of Medical Virology, 48:184-190 (1996).
“Improved serodiagnosis of hepatitis C virus infection with synthetic peptide antigen from capsid protein”,Barbara Hosein et al., Proc. Natl. Acad. Sci. USA, vol. 88, May 1991, pp. 3647-3651.
“Hepatitis E. virus (HEV): The novel agent responsible for enterically transmitted non-A, non-B hepatitis”,Gregory R. Reyes et al., Gastroenterologia Japonica, vol. 26, Suppl. 3, Jul. 1991, pp. 142-147.
“T. C or Not to C: These are the Questions”,Harvey J. Alter, Blood, vol. 85, No. 7, Apr. 1, 1995; pp. 1681-1695.
“Genotype-Dependent Serologic Reactivities in Patients Infected with Hepatitis C Virus in the United States”,Nizar N. Zein, M.D. et al., Mayo Clin. Proc., 1995; 70:449-452.
“Improved serologic detection of hepatitis C virus with a paramagnetic microparticle assay using multiple antigenic sequences”,D. Leahy et al., Transufsion, vol. 32, No. 6, 1992, pp. 548-553.
“Genetic organization and diversity of the hepatitis C virus”,Q.L. Choo et al., Proc. Natl. Acad. Sci. USA, vol. 88 Mar. 1991, pp. 2451-2455.
Zhang et al., Journal of Medical Virology, 45:50-55, 1995.
Bukh et al., Proc. Natl. Acad. Sci. USA, 91:8239-8243, Aug. 1994.
Chien et al., Proc. Natl. Acad. Sci. USA, 89:10011-10015, Nov. 1992.
Fields et al., Clinical and Diagnostic Virology 5:167-179, 1996.
Ruedinger et al., Abstracts of the 97thGeneral Meeting of the American Society for Microbiology, Abstracts in Clinical and Diagnostic Immunology, # V-54, p. 583.
Khudyakov, Yury et al., “New Frontiers in Protein Engineering: Artificial Mosaic Antigens”, 17thInternational Congress of Biochemistry and Molecular Biology in Conjunction with the Annual Meeting of the American Society for Biochemistry and Molecular Biology, San Francisco, California, USA, Aug. 24-29, 1997, FASEB Journal 11 (9), 1997, abstract No. 1574.
Chokri, Bahoul et al, “DNA-Based Immunization for Exploring the Enlargement of Immunological Cross-Reactivity Against the Lyssaviruses”, Vaccine, vol. 16, No. 4, Feb. 1998, pp. 417-425.
Fields Howard A.
Khudyakov Yury E.
Housel James
Needle & Rosenberg P.C.
The United States of America as represented by the Department of
LandOfFree
Mosaic protein and restriction endonuclease assisted... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mosaic protein and restriction endonuclease assisted..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mosaic protein and restriction endonuclease assisted... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3511207